Kristen Hsu

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 6

Top Topics

Multiple Myeloma

Prognostic Factors

Top Venues

Advances in therapy

Patient related outcome measures

This page only lists publications with an associated author ORCID identifier.

Publications

Mathew S Maurer, Prem Soman, Adrian F Hernandez, Pablo García-Pavía, James E Signorovitch, Lee-Jen Wei, Mazen Hanna, Frederick L Ruberg, Michelle M Kittleson, Dhruv S Kazi, Sharmila Dorbala, Kristen Hsu, Isabelle Lousada, Rosalyn O Adigun, Preston Dunnmon, Jeffrey W Kelly, Julian David Gillmore, null null
Advancing Transthyretin Amyloidosis Drug Development in an Evolving Treatment Landscape: Amyloidosis Forum Meeting Proceedings. Advances in therapy 41 (7) (2024)
Mathew S Maurer, Prem Soman, Adrian F Hernandez, Pablo García-Pavía, James E Signorovitch, Lee-Jen Wei, Mazen Hanna, Frederick L Ruberg, Michelle M Kittleson, Dhruv S Kazi, Sharmila Dorbala, Kristen Hsu, Isabelle Lousada, Rosalyn O Adigun, Preston Dunnmon, Jeffrey W Kelly, Julian David Gillmore, null null
Advancing Transthyretin Amyloidosis Drug Development in an Evolving Treatment Landscape: Amyloidosis Forum Meeting Proceedings. Advances in therapy (2024)
Mathew S Maurer, Prem Soman, Adrian F Hernandez, Pablo García-Pavía, James E Signorovitch, Lee-Jen Wei, Mazen Hanna, Frederick L Ruberg, Michelle M Kittleson, Dhruv S Kazi, Sharmila Dorbala, Kristen Hsu, Isabelle Lousada, Rosalyn O Adigun, Preston Dunnmon, Jeffrey W Kelly, Julian David Gillmore, null null
Advancing Transthyretin Amyloidosis Drug Development in an Evolving Treatment Landscape: Amyloidosis Forum Meeting Proceedings. Advances in therapy 41 (7) (2024)
Mathew S Maurer, Prem Soman, Adrian F Hernandez, Pablo García-Pavía, James E Signorovitch, Lee-Jen Wei, Mazen Hanna, Frederick L Ruberg, Michelle M Kittleson, Dhruv S Kazi, Sharmila Dorbala, Kristen Hsu, Isabelle Lousada, Rosalyn O Adigun, Preston Dunnmon, Jeffrey W Kelly, Julian David Gillmore, null null
Advancing Transthyretin Amyloidosis Drug Development in an Evolving Treatment Landscape: Amyloidosis Forum Meeting Proceedings. Advances in therapy 41 (7) (2024)
Mathew S Maurer, Prem Soman, Adrian F Hernandez, Pablo García-Pavía, James E Signorovitch, Lee-Jen Wei, Mazen Hanna, Frederick L Ruberg, Michelle M Kittleson, Dhruv S Kazi, Sharmila Dorbala, Kristen Hsu, Isabelle Lousada, Rosalyn O Adigun, Preston Dunnmon, Jeffrey W Kelly, Julian David Gillmore, null null
Advancing Transthyretin Amyloidosis Drug Development in an Evolving Treatment Landscape: Amyloidosis Forum Meeting Proceedings. Advances in therapy 41 (7) (2024)
Meaghan O'Connor, Kristen Hsu, Lynne E Broderick, Kristen L McCausland, Kaitlin LaGasse, Sabrina Rebello, Michelle K White, Isabelle Lousada
The Transthyretin Amyloidosis - Quality of Life (ATTR-QOL) Questionnaire: Development of a Conceptual Model and Disease-Specific Patient-Reported Outcome Measure. Patient related outcome measures 14 (2023)